Regulation of growth of normal ovarian epithelial cells and ovarian cancer cell lines by transforming growth factor-beta.

OBJECTIVE The purpose of this study was to study the role of transforming growth factor-beta in regulation of proliferation of normal and malignant ovarian epithelial cells. STUDY DESIGN We examined production of and responsiveness to transforming growth factor-beta in primary monolayer cultures of epithelial cells from five normal human ovaries and in five ovarian cancer cell lines. RESULTS In normal ovarian epithelial cells, proliferation always was inhibited by transforming growth factor-beta (greater than 40%) (p less than 0.01). Among the cancer cell lines, proliferation of one was markedly inhibited (greater than 95%) (p less than 0.01), two were only modestly inhibited (15% to 20%) (p less than 0.05), and two were unaffected. In addition, we found that all of the normal ovarian epithelial cells and four of five ovarian cancer cell lines produce transforming growth factor-beta ribonucleic acid and protein. CONCLUSIONS These data suggest that transforming growth factor-beta may act as an autocrine growth inhibitory factor for normal ovarian epithelium in vivo. Because most of the ovarian cancer cell lines are relatively resistant to the growth inhibitory effect of transforming growth factor-beta and because one cell line does not produce transforming growth factor-beta, it is possible that loss of the transforming growth factor-beta pathway may play a role in the development of some ovarian cancers.

[1]  M. Korc,et al.  Differential regulation of expression of three transforming growth factor beta species in human breast cancer cell lines by estradiol. , 1990, Cancer research.

[2]  K. Struhl,et al.  Current Protocols in Molecular Biology (New York: Greene Publishing Associates and Wiley-Interscience). Host-Range Shuttle System for Gene Insertion into the Chromosomes of Gram-negative Bacteria. , 1988 .

[3]  R. Derynck,et al.  Evidence that transforming growth factor-β is a hormonally regulated negative growth factor in human breast cancer cells , 1987, Cell.

[4]  M. Sporn,et al.  Suppression of carcinogenesis: a role for TGF-beta and related molecules in prevention of cancer. , 1990, Immunology series.

[5]  M. Sporn,et al.  Type beta transforming growth factor is the primary differentiation-inducing serum factor for normal human bronchial epithelial cells. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[6]  R. Bast,et al.  The Role of Peptide Growth Factors in Epithelial Ovarian Cancer , 1990, Obstetrics and gynecology.

[7]  S. Bates,et al.  Production of and responsiveness to transforming growth factor-beta in normal and oncogene-transformed human mammary epithelial cells. , 1989, Cancer research.

[8]  R. Weinberg,et al.  Tumor suppressor genes. , 1991, Science.

[9]  H. Moses,et al.  Isolation and characterization of kirsten murine sarcoma virus‐transformed mouse keratinocytes resistant to transforming growth factor beta , 1990, Molecular carcinogenesis.

[10]  R. Bast,et al.  Epidermal growth factor receptor expression in normal ovarian epithelium and ovarian cancer. I. Correlation of receptor expression with prognostic factors in patients with ovarian cancer. , 1991, American journal of obstetrics and gynecology.

[11]  R. Bast,et al.  Overexpression of HER-2/neu is associated with poor survival in advanced epithelial ovarian cancer. , 1990, Cancer research.

[12]  E. Adashi,et al.  Ovarian transforming growth factor-β (TGFβ): cellular site(s), and mechanism(s) of action , 1989, Molecular and Cellular Endocrinology.

[13]  A. Brunner,et al.  Transforming growth factor beta 1: importance of glycosylation and acidic proteases for processing and secretion. , 1989, Molecular endocrinology.

[14]  P. Kruk,et al.  A simplified method to culture human ovarian surface epithelium. , 1990, Laboratory investigation; a journal of technical methods and pathology.

[15]  A. Brunner,et al.  Type 1 transforming growth factor beta: amplified expression and secretion of mature and precursor polypeptides in Chinese hamster ovary cells , 1987, Molecular and cellular biology.

[16]  H. Moses,et al.  Mechanism of activation of latent recombinant transforming growth factor beta 1 by plasmin , 1990, The Journal of cell biology.

[17]  F. Hahn,et al.  Increased resistance to transforming growth factor beta accompanies neoplastic progression of rat tracheal epithelial cells. , 1989, Carcinogenesis.

[18]  K. Osteen,et al.  Ovarian thecal cells produce transforming growth factor-beta which can regulate granulosa cell growth. , 1987, Endocrinology.

[19]  D. Danielpour,et al.  Rat thecal/interstitial cells express transforming growth factor-beta type 1 and 2, but only type 2 is regulated by gonadotropin in vitro. , 1991, Endocrinology.

[20]  N. Auersperg,et al.  Serial propagation of human ovarian surface epithelium in tissue culture , 1988, Journal of cellular physiology.

[21]  Inae Kim,et al.  The production of transforming growth factor-beta activity by rat granulosa cell cultures. , 1989, Endocrinology.

[22]  R. Bast,et al.  Epidermal growth factor receptor expression in normal ovarian epithelium and ovarian cancer. II. Relationship between receptor expression and response to epidermal growth factor , 1991, American journal of obstetrics and gynecology.

[23]  M. Sporn,et al.  Sarcoma growth factor from conditioned medium of virally transformed cells is composed of both type alpha and type beta transforming growth factors. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[24]  J. Dasch,et al.  Monoclonal antibodies recognizing transforming growth factor-beta. Bioactivity neutralization and transforming growth factor beta 2 affinity purification. , 1989, Journal of immunology.

[25]  G. Sato,et al.  Growth of a human mammary tumour cell line in a serum-free medium , 1979, Nature.

[26]  D. Lawrence,et al.  Latent beta-transforming growth factor in nontransformed and Kirsten sarcoma virus-transformed normal rat kidney cells, clone 49F. , 1984, Cancer research.

[27]  C. Daniel,et al.  Reversible inhibition of mammary gland growth by transforming growth factor-beta. , 1987, Science.

[28]  M. O’Connor-McCourt,et al.  Latent transforming growth factor-beta in serum. A specific complex with alpha 2-macroglobulin. , 1987, The Journal of biological chemistry.

[29]  V. Band,et al.  Expression of growth factors and oncogenes in normal and tumor-derived human mammary epithelial cells. , 1988, Cancer research.